| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.32 | 0.09 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |